The Lack of HER-2/neu Oncogene Amplification in Colorectal Malignancies

[1]  H. Stein,et al.  Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis , 2003, British Journal of Cancer.

[2]  S. Yoshida,et al.  Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. , 2002, Gastrointestinal endoscopy.

[3]  H. Stein,et al.  Screening for oesophageal neoplasia in patients with head and neck cancer , 2002, British Journal of Cancer.

[4]  M. Sliwkowski,et al.  Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. , 2001, Gastroenterology.

[5]  Y. Doki,et al.  Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  H. Makuuchi,et al.  Survival Benefit of Screening for Early Esophageal Carcinoma in Head and Neck Cancer Patients , 1998 .

[7]  F. Oberti,et al.  Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? , 1997, Gastrointestinal endoscopy.

[8]  K. Pavelić,et al.  The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. , 1997, Gastroenterology.

[9]  K. Okuyama,et al.  Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining , 1995, Cancer.

[10]  M. Thun.  NSAIDs and esophageal cancer: ready for trials but not yet broad clinical application. , 2003, Gastroenterology.

[11]  A. Potti,et al.  HER-2/neu overexpression in colonic malignancies. , 2002, Gastroenterology.